Repetitive Transcranial Magnetic Stimulation Versus Botulinum Injection on Spasticity on Children With Diplegic Cerebral Palsy

NACompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

October 15, 2023

Primary Completion Date

January 20, 2024

Study Completion Date

August 10, 2024

Conditions
Spastic Diplegic Cerebral Palsy
Interventions
DRUG

botulinum toxin A

Botulinum Neurotoxin A (BoNT-A) Injections will administered directly into the bulk of the muscles, with two injection sites at each head of the gastrocnemius and two sites into the medial hamstring. one vial of BoNT-A in 2 mL of 0.9% sodium chloride solution. followed by a 3-month rehabilitation program. The entire intervention including rTMS, BoNT-A, and rehabilitation training program spanned a period of three months.

DEVICE

Transcranial Magnetic Stimulation

Repeated Transcranial Magnetic Stimulation (rTMS) Stimulation coil will strategically place on the primary motor cortex (M1), The patients received 1500 pulses per session, two sessions per week for 3 months, in a combination with 3-month rehabilitation program.

OTHER

Rehabilitation Training Protocol

Rehabilitation Training Protocol: As part of the study protocol, all participating children underwent a comprehensive weekly routine rehabilitation training program. Training Schedule: sessions will conduct for duration of 45 minutes. Training occurred four days a week.

Trial Locations (1)

Unknown

faculty of pysical therapy, MTI university, Cairo

All Listed Sponsors
lead

MTI University

OTHER

NCT06218316 - Repetitive Transcranial Magnetic Stimulation Versus Botulinum Injection on Spasticity on Children With Diplegic Cerebral Palsy | Biotech Hunter | Biotech Hunter